The increased sensitivity of LUAD to EMT processes activated by drug therapy and the enhancement of tumor metabolic plasticity, regulation of tumor adaptation to hypoxia, and promotion of an aggressive tumor phenotype are consequences of the deficiency in HTATIP2 expression (57). The gene discussed is HTATIP2; the disease is neoplasm.